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Sllmmary 
Stimulation of the T cell antigen receptor (TCK) activates a protein tyrosine kinase and leads 
to the tyrosine phosphorylation of phosphoinositide-specific phospholipase C-'yl (PLC3,1). The 
molecular interactions  involved in this phosphorylation are not known. After stimulation of 
the TCK on Jurkat T cells, tyrosine-phosphorylated proteins of 36, 38, 58, and 63 kD coprecipitate 
with PLC3,1. An identical pattern of proteins precipitate with TrpE fusion proteins that contain 
the Src homology (SH) 2 domains of PLC'y1, indicating that these regions of PLC'y1 are responsible 
for binding. TCR stimulation leads to an association between the SH2 domains of PLC3,1 and 
a protein tyrosine kinase,  which, by peptide mapping,  is identical  to  p56 ~k. These studies 
establish  that  p56 k~ associates with PLC3,1 as a result  of TCK  stimulation of Jurkat  ceils, 
suggesting that p56 ~t plays a central role in coupling the TCR to the activation  of PLC'y1. 
1  ~ctivation of a protein tyrosine kinase (PTK)  plays a cen- 
/  ~. tral role in signal transduction by the TCR (1, 2). Lacking 
intrinsic kinase activity, the TCK likely couples to a Src-like 
PTK, probably p59h", which coprecipitates with the TCR 
(3, 4). A second early TCK-mediated signaling event is the 
activation of a phosphoinositide (PI)-specific phospholipase 
C  (PLC) (5). The resulting PI hydrolysis generates second 
messengers that mobilize intracellular calcium and that acti- 
vate protein kinase C. TCR-mediated PI turnover is sensitive 
to PTK inhibitors, suggesting that tyrosine phosphorylation 
regulates PLC activity (6, 7). Consistent with this possibility, 
stimulation of the TCK on Jurkat T cells leads to the tyro- 
sine phosphorylation of PLC~/1 and, subsequently, to an as- 
sociation between PLCv1 and the CD3 components of the 
TCR (8-t2). 
The molecular interactions  that  are required for TCg- 
mediated activation  of PLCqrl in Jurkat cells, and the PTK 
involved, are not known. Critical to the activation of PLC-/1 
by growth factor receptor protein tyrosine kinases, such as 
1 Abbreviations used in this paper: EGF, epidermal growth factor; GAP, 
GTPase activating protein; PDGF, platelet-derived growth  factor; PI, 
phosphoinositide; PLC3,1, phospholipase C-'yl; PTK, protein tyrosine 
kinase; PVDF, polyvinylidene ditluoride. 
the receptors for epidermal growth factor (EGF) and platdet- 
derived growth factor (PDGF), is the direct binding of PLCT1 
to the receptor (13-17). This binding requires autophosphor- 
ylation of the receptor  and appears to be mediated by the 
Src homology 2 (SH2) domains of PLC3,1 (18-20). SH2 do- 
mains are conserved sequences of '~100 amino acids that are 
found in a number of signaling  molecules (20). By recog- 
nizing specific peptide sequences that contain phosphotyro- 
sine, SH2 domains likely play a key role in directing pro- 
tein-protein interactions  during signal  transduction (20). 
Herein, we have examined the possibilities that PLC'y1 as- 
sociates with tyrosine phosphorylated molecules as a result 
of TCR stimulation of Jurkat cells, and that this association 
involves the SH2 domains of PLC'yl. 
Materials and Methods 
Reagents.  TrpE fusion proteins containing the SH2 domains 
of PLC3q and ras GTPase activating protein (GAP) were isolated 
from Escherichia coli RR1 possessing the appropriate pATH expres- 
sion plasmid as described (18, 19). Rabbit antisera to pSC  k and 
to PLC3~I  were supplied by Drs. J. Bolen (Bristol-Meyers  Squibb, 
Princeton, NJ) and R. Schatzman  (Syntex  Corp., Palo Alto, CA), 
respectively.  Jurkat cells and the mAb C305 (reactive  with the Jurkat 
TCK) were gifts of Dr. A. Weiss (University of California, San 
Francisco, CA). 
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Imraunoblotting.  Cells were lysed in an ice-cold buffer containing 
1% Triton X-100 as described (18). After a 30-min incubation  on 
ice, the lysates were subjected to a 15-rain centrifugation  at 14,000 
g. To immunoprecipitate  PLC3,1 or p56  k~, the clarified lysate was 
incubated with the appropriate rabbit antiserum complexed to Pan- 
sorbin (Calbiochem Corp., La Jolla, CA). For precipitations with 
the TrpE fusion proteins, lysates were incubated with the indicated 
TrpE fusion protein immob'flized  by a T_rpE  mAb (Oncogene Science, 
Inc., Manhasset,  NY) complexed to Pansorbin with a rabbit  an- 
tiserum  to mouse Ig (Cappel Laboratories, Durham, NC). After 
incubation with the Jurkat lysate for 90 min at 4~  the precipita- 
tion complexes were recovered by centfifugation,  washed  three 
times, and then  duted in Laemmli sample buffer. Samples were 
subjected to electrophoresis under reducing conditions in 5-15% 
polyacrylamide gradient gels, transferred to polyvinylidene difluo- 
ride (PVDF) membranes (Millipore Corp., Bedford, MA), and ana- 
lyzed by immunoblotting with a mouse IgG2b mAb (4G10) to 
phosphotyrosine  (Upstate Biologicals, Inc., Lake Placid, NY), re- 
vealed by an alkaline phosphatase-conjugated  mAb specific  for mouse 
IgG2b (PharMingen,  San Diego,  CA). 
In  Vitro Kinase Assays.  Precipitation  complexes were washed 
in a kinase wash buffer (1% Triton X-100; 150 mM NaC1; 50 mM 
Hepes, pH 7.5; 1 mM Na3VO~), incubated for 15 rain on ice with 
27 #Ci/sample  3r  (Amersham International,  Amersham, 
Bucks, UK, 6,000 Ci/mmole) in a kinase reaction buffer (100 mM 
NaC1; 20 mM Hepes, pH 7.4; 5 mM MnCh; 5 mM MgC12) (final 
vol, 25 #1), and then washed twice in the above wash buffer con- 
taining  1 mM EDTA. The reaction products  were solubilized in 
Laemmli  sample buffer  and  resolved by  electrophoresis  under 
reducing conditions in 5-15% polyacrylamide gels. After fixation 
for 1 h in 10% ghcial acetic acid/10% isopropanol, the gds were 
treated with 1 M KOH for 2 h at 55~  followed by incubation 
in  10% glacial acetic acid/10% isopropanol. 
Peptide Mapping and Phosphoamino Acid Analysis.  In vitro ki- 
nase reactions using precipitations from lysates of TCR-stimulated 
Jurkat cells were analyzed as described above except that  the gels 
were not treated with KOH. For peptide mapping,  the bands of 
interest were identified by autoradiography, precisely excised from 
the dried gel, rehydrated, and digested with staphylococcal  V8 pro- 
tease (Calbiochem Corp.) as described by Cleveland et al. (21). For 
phosphoamino  acid analysis, the 32p-labeled proteins  were trans- 
ferred to PVDF membranes, duted, and then hydrolyzed in 6N 
HCI for 1 h at 110~  as described (22). Phosphoamino acids were 
resolved  on thin-la~ cellulose  plates  by two-dimensinnal electropho- 
resis using a Hunter thin-layer electrophoresis system (HTLE-7000; 
CBS Scientific, Dd Mar, CA) (22). 
Results 
The addition  of a TCK mAb to Jurkat cells induces the 
tyrosine phosphorylation  of PLC3,1  (8-12).  When  PLC3'I 
is immunopredpitated from lysates of TCRostimulatedJurkat 
cells, we observe that four prominent tyrosine-phosphorylated 
proteins of 36, 38, 58, and 63 kD (pp36, pp38, pp58,  and 
pp63) consistently coprecipitate with PLC3,1 (Fig. 1). To de- 
termine whether the coprecipitation of these rnolecules is a 
result of their binding  to the SH2 domains of PLC'y1, we 
used fusion proteins  of TrpE  and PI.C'y1 SH2 domains  as 
affinity ligands.  Fusion  proteins  that  have both  the  NH2- 
and COOH-terminal PLC3,1 SH2 domains precipitate tyro- 
sine-phosphorylated  proteins  that  exactly  comigrate  with 
Figure 1.  Tyrosine-phosphoryhted  proteins  from  TCR-stimulatedJurkat 
cells coprecipitate  with PLCT1 and bind to TrpE fusion  proteins containing 
the NH2 SH2 domain of PLC~I. Jurkat cells (8 x  10~ cells/sample) were 
stimulated for 2 rain at 37~  with the TCR mAb C305 and then lysed 
with an ice-cold  buffer  containing 1% Triton X-100 and phosphatase in- 
hibitors as described  (13). Endogenous PLCT1 was immunoprecipitated 
using a specific  antiserum as described  in Materials and Methods. Alterna- 
tively, lysates  were subjected  to precipitations using TrpE fusion proteins 
that contained both the NHz- and COOH-terminal SH2 domains of 
PLC'y1 (PLC,  T-SH2), the  NH2-terminal SH2 domain alone (PLCT1- 
SH2[N]), the COOH-terminal domain alone (PI..C~/I-SH2[C]),  or the 
NH2- and COOH-terminal SH2 domains of p21  r~' GAP (GAP-SH2). 
After resolution under reducing conditions on SDS-PAGE and transfer 
to PVDF membranes, tyrosine-phosphorylated  proteins were detected  by 
immunoblotting. The 150-kD tyrosine-phosphoryhted  band in the PLC3'I 
immunoprecipitate comigrates with PLC3'I as detected  by immunoblot- 
ting with anti-PLCqel (data  not shown). (Arrows)  Tyrosine-phosphoryhted 
proteins of 36, 38, 58, and 63 kD that coprecipitate with endogenous 
PLC3'I and with TrpE fusion proteins containing the NH2-terminal SH2 
domain of PI.C'I,1. 
PLC'yl-associated molecules.  Comparable levels  of all  four 
tyrosine-phosphorylated proteins also bind to a fusion pro- 
rein that has only the NH2-terminal  SH2 domain.  In con- 
trast, a fusion protein containing the COOH-terminal PLCT1 
SH2 domain precipitates only barely detectable levels ofpp58 
and pp63 molecules and does not precipitate pp36 and pp38 
(Fig.  1). The NH2-terminal SH2 domain,  therefore, appears 
to be primarily responsible for the binding of these tyrosine- 
phosphorylated molecules to PLC'y1. The binding is specific 
for PLCT1 SH2 domains in that little or no binding is ob- 
served with a TrpE fusion protein that contains the SH2 do- 
mains  of p21  '~ GAP (Fig.  1) or with  TrpE  alone (Fig.  2). 
The TrpE/p21 ~' GAP fusion protein effectively precipitates 
tyrosine-phosphorylated PDGF and EGF receptors (18,  19). 
Only low level binding of the tyrosine-phosphorylated pro- 
teins to the TrpE/PLC'y1 SI-I2 fusion protein is detected in 
lysates from unstimulated Jurkat cells (Fig. 2). Similarly,  these 
molecules are either absent or only barely detectable when 
the endogenous PLCT1 is immunoprecipitated from unstimu- 
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teins to a TrpE fusion protein containing the NH2- and COOH-terminal 
SH2 domains of PLC3,1. Jurkat cells (2  ￿  107 cellsAample)  were either 
lysed directly (0) or stimulated with the TCK mAb C305. At the indi- 
cated time interval, the reactions were terminated by the addition of ice- 
cold lysis  buffer. Precipitation experiments using either TrpE alone or the 
TrpE/PI.C'yl fusion  protein were performed  and, after electrophoresis  under 
reducing conditions on SDS-PAGE  and transfer to I'VDF, were analyzed 
by antiphosphotyrosine immunoblotting  as described in Materials and 
Methods. The H and L chains of the precipitating antibodies are visible 
in each lane and are seen in control immunoblots developed  in the absence 
of the antiphosphotyrosine mAb (data not shown). 
lated cells (data not shown).  Within 30 s of TCK stimula- 
tion a  substantial  increase in the binding  of all four mole- 
cules occurs (Hg. 2). Binding is maximal by 45 s and declines 
after 2 rain (Fig. 2). In most, but not all experiments (com- 
pare Figs.  1 and  2),  we observed induced bands of 72  and 
105 kD  at the earliest time points,  a well as a 55-kD band 
whose binding  was  unaffected by receptor stimulation. 
To determine whether a FTK associates with PLCy1, we 
performed in vitro kinase reactions using precipitates with 
the TrpE/PLC'y1  SH2 fusion protein  and  immunoprecipi- 
tates of the endogenous PLC'y1 (Fig. 3, A  and B). There is 
little or no kinase activity in precipitates from unstimulated 
cells or in precipitates using TrpE alone. After TCR stimula- 
tion, a protein kinase precipitates with the TrpE/PLCyl SH2 
domain fusion protein and with the endogenous PLC'y1. In 
both cases, the in vitro kinase reaction yields a  prominent 
doublet of phosphoproteins of 58 and 63 kD. Phosphoamino 
acid analysis of each of these phosphoproteins demonstrated 
that the phosphorylation occurred in tyrosine residues (Fig. 
3,  C,  and  data not  shown). 
The 58 kD and 63 kD  tyrosine-phosphorylated proteins 
that  associate  with  PLC'y1  have  apparent  Mr  similar  to 
p59f~ and to p56  ~,  a Src-like FFK which is noncovalently 
associated with the CD4 and CD8 coreceptors and which, 
because of differential serine phosphorylation,  has two elec- 
Figure 3.  Detection of a FTK activity 
in precipitates  of the endogenous PLCv1 
and in TrpE  fusion  protein containing  the 
NH2-  and  COOH-terminal  SH2  do- 
mains of PI.C~I.  (.4) Jurkat cells were 
either lysed  directly (-) or after stimula- 
tion (+) for 2 min with the TCR mAb 
C305.  The dried  gel  was  exposed to 
Kodak X-OMAT film (Eastman Kodak 
Co., Rochester, NY) for 8 h. Each lane 
represents the reaction  products  generated 
by precipitations from 20  x  106 cells. 
(B) Jurkat cells  were either lysed  directly 
(-)  or after stimulation (+) with the 
TCR mAb C305. Precipitatiom  were  per- 
formed using TrpE alone, the TrpE fu- 
sion protein containing the NH2- and 
COOH-terminal  SH2  domains  of 
PLC'y1, or a rabbit antiserum to p56  ~k. 
Kinase reactions  were performed,  and the 
reaction products analyzed as described 
in Materials and Methods. The autoradi- 
ograph was exposed  for 3 h. The reaction 
products of the p56~i immunoprecipi- 
tares are from 106 Jurkat cells, whereas 
the other lanes represent precipitations 
from 10  x  106 cells. (C) Phosphoamino 
acid analysis  of the 62-kD phosphoprotein 
generated from an in vitro kinase assay 
using the TrpE/PLC'y1-SH2  fusion pro- 
tein. The positions of the phosphoamino 
acid standards are shown. 
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photyrosine immunoblots, the two PLC3rl-associated mole- 
cules  comigrate  with  p56  kk  immunoprecipitated  from 
TCR-stimulated Jurkat cells (data not shown). Furthermore, 
p56  ~k, which autophosphorylates during in vitro kinase reac- 
tions  (23-26),  comigrated  with  the  58-  and  63-kD  phos- 
phoproteins observed with in vitro kinase reactions from ei- 
ther  immunoprecipitated  PLC',/1  or  the  fusion  protein 
precipitates (Fig. 3 B). To confirm that the PLC'~l-associated 
molecules are p56  kk, we compared the peptide maps of the 
phosphoproteins.  As shown in Fig. 4, the maps of the phos- 
phoproteins generated from precipitates of the TrpE/PLC'y1 
SH2 fusion protein  are identical  to  those from p56  ~k. 
Because  TCR  ligation  induced  an  association  between 
PLC3~I and tyrosine-phosphorylated p56  ~,  we determined 
whether TCR stimulation altered the tyrosine phosphoryla- 
tion of the latter. Consistent with previous reports that some 
p56  ~k is tyrosine-phosphorylated in unstimulated T  cell lines 
(25, 26), we observed that p56  ~k immunoprecipitated  from 
unstimulatedJurkat cells contained phosphotyrosine (Fig. 5). 
There was a clear increase in the tyrosine phosphorylation 
of p56  ~k within  60  s  of TCR  stimulation  (Fig.  5,  second 
lane). In contrast to the immunoprecipitates from resting cells, 
several tyrosine-phosphorylated molecules coprecipitated with 
p56  ~k from TCR-stimulated cells. The apparent Mr of these 
molecules are identical to those of the 36-, 38-, and 72-kD 
molecules that  associate with  PLC3q  (Fig.  5,  second  lane). 
We then precleared lysates with the TrpE/PLC3~I  SH2 do- 
main fusion protein  to deplete the lysates of the molecules 
that  bind PLC3q.  This preclearing  removed the molecules 
that  coprecipitate  with  p56  ~k,  confirming  that  these were 
identical  to the PLC3,1-associated  molecules (Fig.  5, fourth 
lane). Moreover, preclearing the lysates from TCR-stimulated 
cells reduced the amount  of tyrosine-phosphorylated p56  ~k 
to the levels of unstimulated cells (Fig.  5, compare the second 
and  fourth lanes). Consistent with the absence of PTK activity 
in precipitations from unstimulated cells (Fig.  3), the fusion 
protein  did not remove any tyrosine-phosphorylated  p56  ~k 
from the lysates of unstimulated  cells  (Fig.  5, compare the 
first  and  third lanes). 
Discussion 
We observe that stimulation  of the TCR on Jurkat cells 
leads to the binding of several tyrosine-phosphorylated mol- 
ecules,  including  p56  t'k,  to  PLC'y1.  Studies  using 
TrpE/PLC3/1 fusion proteins indicate that these associates are 
mediated by the SH2 domains of PLC'y1, the same region 
of PLC'yl that binds to the tyrosine~phosphorylated EGF and 
PDGF receptors.  The association with p56  ~  occurs within 
30 s of TCR stimulation and thus coincides with the onset 
of tyrosine phosphorylation of PLC'y1 in Jurkat cells (8-11). 
The interaction between PLC'y1 and p56  ~k is transient  and 
peaks several minutes before the reported association of PLC3,1 
with CD3 (12). The time course of the association between 
Figure 4.  Comparison  of  the V8 protease  peptide  maps of  the comigrating 
phosphoproteins generated by in vitro kinase reactions using p56  uk im- 
munoprecipitations from 10~ Jurkat calls and precipitations with the 
TrpE/PLC'y1 SH2 fusion protein from 10 x  10  ~  Jurkat cells. The diges- 
tion products were resolved under reducing conditions on a 15  % poly- 
acrylamide  gel and visualized  by exposing  the dried  gel to Kodak  X-OMAT 
film (Eastman Kodak Co.) for 24 h. Lanes I: (upper  band) TrpE/PI.C3,1 
fusion protein reaction, 2: (upper  band)  anti-LCK reaction; 3: (lower  band) 
TrpE/PLC'yl fusion protein reaction; 4: (lower  band) anti-LCK reaction. 
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Figure 5.  Effect  of TCR stimulation 
on  the  tyrosine phosphorylation of 
p56  ~k. Jurkat cells (2 x  107 cens/saraple) 
were either lysed  directly (-) or stimu- 
lated with a TCK mAb for 60 s before 
lysis (+). p56  k/' was immunopredpitated 
with a specific  antiserum, resolved  by dec= 
trophoresis under reducing  conditions on 
SDS-PAGE, transferred to PVDF, and 
then analyzed  by immunoblotting with 
a mAb to phosphotyrosine. In the third 
and fourth  hnes, the lysates  were  predeared 
with the TrpE/PI.C3,1 SH2 domain fu- 
sion protein before the immunoprecipi- 
tation of p56  k~. p56  uk and PLC'F1, therefore, is consistent with the possi- 
bility that p56  uk plays a role in TCR-mediated activation of 
PLC~/1. p56  ~  may be partly or solely responsible for tyro- 
sine phosphorylation of PLC3/1. Alternatively,  p56  ~  may 
phosphorylate molecules that associate with PLC3,1, and that 
are involved in its activation. 
Our results lend additional support to earlier indications 
that p56  u~ may participate in TCK-mediated signaling. Re- 
cently Abraham et al. (27) observed augmented responses to 
antigen after expression of an activated form of p56  ~  in an 
antigen-specific T cell hybridoma. This augmentation occurred 
in the absence of cell-surface expression of CD4 and CD8 
and, therefore, was independent of coreceptor ligation (27). 
In T  cells that express CD4 or CDS,  "~30-60%  of p56  u~ 
is complexed to these coreceptors (23-26). Interactions with 
p56  ~  appear to be at least partly responsible for the ability 
of CD4 to confer enhanced antigen responses upon T  cell 
dones and hybridomas (28). CD4 may be physically associated 
with the TCK, and there is evidence that maintaining CD4 
and TCK in physical proximity enhances TCR-mediated fig- 
naling (29,  30).  For example,  in mAb-induced signaling, 
codustering of the TCK and CD4 (by means of heterocon- 
jugates of mAb) substantially augments TCR-mediated PI 
turnover, whereas crosslinking CD4 and the TCK indepen- 
dently diminishes this response (31). 
In contrast to the findings presented here with p56  uk, we 
could not detect p59f~ in our PLC3,1 precipitates  (data not 
shown), p59fr" coprecipitates with the TCR, and there are 
compelling data that p59~ has a role in TCK-mediated sig- 
naling (3, 4). For example, T cells from transgenic mice that 
overexpress  p59f~  have  enhanced  TCK-mediated  Ca  2§ 
mobilization, suggesting that p59fr" regulates the coupling 
of the TCR to PI turnover (4). Our inability to detect an 
association  between  p59~  and  PLC3,1 does  not  argue 
against a role for this, or any other PTK in TCR-mediated 
phosphorylation of PLC3,1. Activation of an "upstream" FTK, 
such as p59fr", might induce PLC3,1 phosphorylation in- 
directly by  triggering the interaction between p56  ~k and 
PLC3~I. Alternatively, an association  between PLC~/1 and 
p59fr" (or other PTKs) might not be stable under the con- 
ditions used here for precipitation. We also cannot be certain 
that p56  ~  is the only FFK present in our PLC3,1 precipi- 
tates, particularly in view of the precipitation of tyrosine- 
phosphorylated molecules (pp36, pp38, pp72, ppl05) whose 
identity is uncertain. 
The p56  kk that associates with PLC3,1 represents <5% of 
the p56  kk that can be immunopredpitated directly with a 
specific antiserum (note that, in Fig. 3, one-tenth the cell 
number was used for the p56  ~k immunoprecipitates). The 
precise mechanism by which the TCK induces an association 
between PLC3,1 and this subset of p56  ~  remains to be de- 
termined. We find that TCR stimulation triggers an increase 
in the tyrosine phosphorylation of p56  ~k and that preclearing 
the lysates of PLC~/1-binding  proteins reduces  the level of 
tyrosine-phosphorylated p56  ~  to that of unstimulated cells. 
This observation, coupled with the inability of PLC3'I to 
bind to p56  ~k from unstimulated cells, suggests that PLC3,1 
selectively binds the subset  of p5C  ~ that is tyrosine phos- 
phorylated as a result of TCK stimulation. We are currently 
investigating whether this reflects phosphorylation of different 
tyrosine residues of p56  ~k and whether the PLC71-associated 
p56  ~  derives  from the pool that is associated with CD4. 
Another important issue is whether interaction with a small 
fraction of cellular pSC  k can account for PLC~/1 phosphory- 
lation. It is interesting in this regard that the tyrosine phos- 
phorylation of PLC3,1 after TCK stimulation appears to in- 
volve <5%  of cellular  PLC71,  with only 1%  of PLCyl 
associating  with CD3 (12). 
In addition to p56  ~k, we observed several other tyrosine- 
phosphorylated molecules that associate with PLC3,1 as a re- 
sult of TCR stimulation. The identities of these molecules 
are not known. Their size distinguishes them from known 
components of the TCR complex. The time course for the 
binding of the pp36 and pp38 molecules to the PLC3'I SH2 
fusion protein is very similar to that of p56  ~k. The presence 
of pp36, pp38, and p56  ~  in the PLC3,1 precipitates suggests 
two  general  models  for  the  association  of  p56  ~k  with 
PLC3,1. In the first model, p56  ~k binds directly to the SH2 
domains of PLC3,1, and this binding is independent of pp36 
and pp38. In the alternative model, the association of p56  ~i 
with PLC3,1 requires  the participation of pp36 and pp38. 
For example, p56  lck might bind directly to pp36 and pp38, 
and the resulting complex would interact with the SH2 do- 
mains of PI.C3~1. In this model, pp36 and p38 would sub- 
serve a docking function that allows the physical approxima- 
tion of p56  ~k and PLC3,1, and the tyrosine phosphorylation 
of pp36 and pp38 could represent a key step in TCR-mediated 
activation of PLC3,1. Further characterization of pp36 and 
pp38 should distinguish between these possibilities and shed 
light on the physiological functions of these molecules. 
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